Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The road to refractory graft-versus-host disease is paved with good intentions

Journal article

North D. and Chakraverty R., (2024), Journal of Clinical Investigation, 134

CAR-T Cells and Recent Advances in Clinical Cellular Immunotherapy


Gu Y. et al, (2022), Practical Transfusion Medicine: Sixth Edition, 543 - 553

Graft-versus-host disease: a disorder of tissue regeneration and repair.

Journal article

Chakraverty R. and Teshima T., (2021), Blood

Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell Transplantation.

Journal article

Marzolini MAV. et al, (2021), Transplant Cell Ther, 27, 682.e1 - 682.e12

Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease

Journal article

Zeiser R. et al, (2021), New England Journal of Medicine, 385, 228 - 238

Graft Versus Leukemia: Current Status and Future Perspectives.

Journal article

O'Neill AT. and Chakraverty R., (2021), J Clin Oncol, 39, 361 - 372

Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity.

Journal article

Dertschnig S. et al, (2020), J Clin Invest, 130, 1896 - 1911

Load More